Literature DB >> 17067658

Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis.

Oded Kimhi1, Dan Caspi, Natan M Bornstein, Nitsan Maharshak, Alexander Gur, Yaron Arbel, Doron Comaneshter, Daphna Paran, Irena Wigler, David Levartovsky, Shlomo Berliner, Ori Elkayam.   

Abstract

OBJECTIVES: To evaluate the extent of subclinical atherosclerosis by measuring the intima-media wall thickness (IMT) of the common carotid artery in patients with psoriatic arthritis (PsA) and to identify vascular risk factors associated with PsA.
METHODS: Forty-seven patients with PsA were compared with 100 allegedly healthy subjects. Carotid duplex scanning was used to measure common carotid artery IMT. Traditional risk factors, such as gender, age, body mass index (BMI), hypertension, smoking, and lipids were checked. Assessment of PsA activity included clinical patterns of involvement, degree of severity, duration of morning stiffness, number of tender and swollen joints, degree of pain and fatigue, the Bath Ankylosing Spondylitis Disease Activity Index, the Psoriasis Area and Severity Index, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and fibrinogen.
RESULTS: The average IMT (mean +/- standard deviation) for PsA patients was significantly higher compared with controls (0.76 +/- 0.11 versus 0.64 +/- 0.27, respectively, P < 0.00001) for the whole group and after adjustment for age, gender, BMI, hypertension, and hyperlipidemia. The PsA subjects had significantly higher levels of hypertension, hyperlipidemia, ESR, CRP, and fibrinogen, and their average IMT significantly correlated with age, BMI, duration of skin and joint disease, spine involvement, ESR, and fibrinogen. IMT did not correlate with the presence of oligo- or polyarthritis but was increased in patients with clinical spinal involvement. IMT was not associated with the degree of severity or the use of different therapies for PsA, including methotrexate or tumor necrosis factor-alpha-blocking agents.
CONCLUSIONS: PsA patients exhibited greater IMT than healthy controls. Increased IMT independently correlated with parameters of disease activity and conventional risk factors of atherosclerosis.

Entities:  

Mesh:

Year:  2006        PMID: 17067658     DOI: 10.1016/j.semarthrit.2006.09.001

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  48 in total

1.  The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors:  Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal:  P T       Date:  2010-12

2.  Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity.

Authors:  Baris Yilmazer; Tayfun Sahin; Berrin Öztaş Unlu; Hale Maral Kir; Ayse Cefle
Journal:  Rheumatol Int       Date:  2015-02-11       Impact factor: 2.631

Review 3.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Authors:  Kerry Wright; Cynthia S Crowson; Sherine E Gabriel
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

4.  Carotid intima-media thickness and epicardial fat thickness predict precoronary artery disease status in psoriasis.

Authors:  Banavasi Shanmukha Girisha; Shajahan Shibina; U Raghuraja; K Subramanyam
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 May-Jun       Impact factor: 2.545

5.  Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis.

Authors:  Monalyn Labitigan; Asena Bahče-Altuntas; Joel M Kremer; George Reed; Jeff D Greenberg; Nicole Jordan; Chaim Putterman; Anna Broder
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

6.  Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women.

Authors:  Shaowei Wu; Wen-Qing Li; Jiali Han; Qi Sun; Abrar A Qureshi
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

7.  Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis.

Authors:  Marco Gentile; Rosario Peluso; Matteo Nicola Dario Di Minno; Luisa Costa; Francesco Caso; Biagio de Simone; Gabriella Iannuzzo; Raffaele Scarpa; Paolo Rubba
Journal:  Clin Rheumatol       Date:  2016-07-13       Impact factor: 2.980

Review 8.  Cardiometabolic Disorders in Psoriatic Disease.

Authors:  Curtis Sobchak; Lihi Eder
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

Review 9.  Vascular effects of biologic agents in RA and spondyloarthropathies.

Authors:  Zoltán Szekanecz; György Kerekes; Pál Soltész
Journal:  Nat Rev Rheumatol       Date:  2009-11-10       Impact factor: 20.543

Review 10.  New insights into the pathogenesis and genetics of psoriatic arthritis.

Authors:  Kristine E Nograles; Richard D Brasington; Anne M Bowcock
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.